Bolt Biotherapeutics (BOLT) Research & Development (2020 - 2026)
Bolt Biotherapeutics' Research & Development came in at $5.15 million for Q2 2026, down 31.3% from $7.5 million a year earlier but up 6.6% from the prior quarter.
Powered by 
Analysis
Bolt Biotherapeutics (BOLT) Research & Development (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Bolt Biotherapeutics reported Research & Development of $21.5 million, down 49.4% year-over-year; for FY2025, it came in at $28.53 million, down 50.4% from FY2024.
- Research & Development has declined in each of the last four years, with a five-year compound annual growth rate of -6.7% (FY2020 to FY2025).
- Going back by year, Research & Development was $57.47 million in FY2024 (-6.6%), $61.54 million in FY2023 (-15.8%), $73.12 million in FY2022 (-3.3%) and $75.66 million in FY2021 (+87.5%).
- The five-year range for quarterly Research & Development is $4.83 million (Q1 2026) to $22.48 million (Q4 2021).
- Year-over-year, Research & Development has declined for nine consecutive quarters, with an average decline of 40.1% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q3 2021 (growth of 102.7%), and the weakest in Q4 2025 (a decline of 57.4%).
- Business Quant data shows BOLT's Research & Development at $4.83 million (Q1 2026), $4.99 million (Q4 2025) and $6.54 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Bolt Biotherapeutics | 6.88 Mn | 6.88 Mn | - | 5.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.15 Mn |
| Mar 31, 2026 | 4.83 Mn |
| Dec 31, 2025 | 4.99 Mn |
| Sep 30, 2025 | 6.54 Mn |
| Jun 30, 2025 | 7.50 Mn |
| Mar 31, 2025 | 9.51 Mn |
| Dec 31, 2024 | 11.72 Mn |
| Sep 30, 2024 | 13.79 Mn |
| Jun 30, 2024 | 15.43 Mn |
| Mar 31, 2024 | 16.53 Mn |
| Dec 31, 2023 | 16.32 Mn |
| Sep 30, 2023 | 14.95 Mn |
| Jun 30, 2023 | 15.64 Mn |
| Mar 31, 2023 | 14.63 Mn |
| Dec 31, 2022 | 16.85 Mn |
| Sep 30, 2022 | 18.97 Mn |
| Jun 30, 2022 | 18.92 Mn |
| Mar 31, 2022 | 18.39 Mn |
| Dec 31, 2021 | 22.48 Mn |
| Sep 30, 2021 | 19.34 Mn |
API Access
Bolt Biotherapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BOLT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BOLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BOLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();